14th Feb 2005 12:00
FULL YEAR 2004 RESULTS PRESENTATION - 2 March 2005 Basingstoke, UK and Philadelphia, PA, US - 14 February 2005 - ShirePharmaceuticals Group plc (LSE: SHP, NASDAQ: SHPGY; TSX: SHQ) will announcefull year 2004 earnings on Wednesday, 2 March 2004.Results announcement time: 12:00 GMT / 07:00 ET Conference call time: 14:00 GMT / 09:00 ET Live analyst presentation and conference call:Matthew Emmens, Chief Executive Officer and Angus Russell, Chief FinancialOfficer will host the investor and analyst meeting and live conference call at14:00 GMT/9:00 ET. The venue for the meeting will be at the offices of DeutscheBank - Winchester House, 75 London Wall, London EC2N 2DB.Please RSVP [email protected] (T: +44 (0)1256 894 160).Live conference call:The details of the live conference call are as follows:UK dial in +44 (0) 1452 568 061 US / Canada dial 1 866 224 2972 in Password Shire Live Webcast:The call will also be available live over the Internet via audio webcast,accessible through www.shire.com in the investor relations section. A slidepresentation to accompany the call will also be available on the Shire website.Replay:A replay of the presentation will be available for two weeks. Details are asfollows:UK dial in 0845 245 5205 US / Canada dial in 1 866 247 4222 Stnd Int Dial In +44 (0) 1452 55 00 00 Number Pin code 2621580# Webcast Replay www.shire.com, in the investor relations section If you have any problems accessing this, please contact: Souheil Salah on: +44(0) 1256 894160 End For further information please contact:Souheil Salah - Investor Relations +44 (0)1256 894 160 Notes to editorsShire Pharmaceuticals Group plcShire Pharmaceuticals Group plc (Shire) is a global specialty pharmaceuticalcompany with a strategic focus on meeting the needs of the specialist physicianand currently focuses on developing projects and marketing products in theareas of central nervous system (CNS), gastrointestinal (GI), and renaldiseases. Shire has operations in the world's key pharmaceutical markets (US,Canada, UK, France, Italy, Spain and Germany) as well as a specialist drugdelivery unit in the US.For further information on Shire, please visit the Company's website: www.shire.com.ENDRelated Shares:
Shire